Last reviewed · How we verify

NCT03946150

PaO2/FiO2*PEEP (P/FP) Ratio and Mortality in Acute Respiratory Distress Syndrome.

Completed Last updated 26 March 2020
What this trial tests

trial testing P/FP Ratio in Adult Respiratory Distress Syndrome in 4,361 participants. Completed in 3 March 2020.

Timeline
1 June 2017
Primary endpoint
5 May 2019
3 March 2020

Quick facts

Lead sponsorNational University Health System, Singapore
StatusCompleted
Study typeOBSERVATIONAL
Enrollment4,361
Start date1 June 2017
Primary completion5 May 2019
Estimated completion3 March 2020
Sites1 location across Singapore

Drugs / interventions tested

Conditions studied

Sponsor

National University Health System, Singapore

Who can join

Adults 18 to 100, any sex, with Adult Respiratory Distress Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The PaO2/FiO2 (P/F) ratio is same for all the Positive End Expiratory Pressure (PEEP) ≥ to 5. This P/F ratio misleads the severity of disease without the knowledge of set PEEP. The Oxygenation status is actually worse when the patient is using high PEEP. P/F Ratio doesn't include PEEP in the calculation.The P/F ratio doesn't show the severity of the disease appropriate for the set PEEP. PaO2/(FiO2 X PEEP) P/FP Ratio is a new Formula which addresses this gap to appropriately calculate the severity of the disease by including PEEP in the formula. This formula is used to predict mortality for different severities of ARDS.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. P/FP ratio: incorporation of PEEP into the PaO<sub>2</sub>/FiO<sub>2</sub> ratio for prognostication and classification of acute respiratory distress syndrome.
    Palanidurai S, Phua J, Chan YH, Mukhopadhyay A. · · 2021 · cited 41× · PMID 34370116 · DOI 10.1186/s13613-021-00908-3

Verify or expand the search:

Other National University Health System, Singapore trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03946150.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing